| Cash Flow | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Net income | 2,889,300 | 1,981,300 | 956,200 | 2,651,200 |
| Stock-based compensation | 65,900 | 41,900 | 21,200 | 62,400 |
| Amortization of purchased intangibles | 167,500 | 111,300 | 55,200 | 166,400 |
| Depreciation and amortization | 81,000 | 54,600 | 27,300 | 87,000 |
| Net realized and unrealized (gains) losses on investments | 3,000 | 2,600 | 2,600 | 11,700 |
| Deferred income taxes | -27,400 | -20,700 | -7,400 | -21,900 |
| Accounts receivable | 69,900 | 95,400 | 196,800 | 95,200 |
| Other current assets | 21,900 | 24,600 | 0 | -598,700 |
| Other assets | -81,400 | -29,800 | -16,500 | -38,100 |
| Accounts payable | -5,000 | 12,500 | 20,300 | 39,300 |
| Income taxes payable | 27,600 | 28,300 | 280,900 | -128,000 |
| Other current liabilities | -9,300 | 67,900 | -57,100 | -691,400 |
| Other liabilities | -7,600 | -9,200 | -2,800 | -17,000 |
| Other | 25,400 | 0 | -5,700 | 5,300 |
| Net cash provided by (used in) operating activities | 3,143,200 | 2,175,100 | 1,116,600 | 2,672,600 |
| Proceeds from maturities of available-for-sale marketable securities | 6,200 | 4,800 | 3,600 | 4,900 |
| Purchases of available-for-sale marketable securities | 4,900 | 3,800 | 3,000 | 4,300 |
| Purchases of property, net | 51,000 | 32,600 | 14,200 | 67,800 |
| Investments in privately-held equity investments | 3,400 | 2,400 | 2,400 | 3,600 |
| Proceeds from sales of investments | 0 | 0 | - | 13,500 |
| Net cash used in investing activities | -53,100 | -34,000 | -16,000 | -57,300 |
| Proceeds from debt, net of issuance costs | 740,600 | 742,300 | 742,300 | - |
| Repayment of debt | 750,000 | 750,000 | 750,000 | 0 |
| Cash dividends | 3,478,000 | 3,022,700 | 2,567,400 | 3,165,400 |
| Repurchase of class a common stock, including costs | 8,200 | 8,200 | - | - |
| Change in performance bond and guaranty fund contributions | -50,145,700 | -43,262,500 | -21,799,100 | -9,264,500 |
| Employee taxes paid on restricted stock vesting | 31,000 | 8,800 | 8,200 | 29,500 |
| Other | -8,800 | -4,500 | -4,400 | -9,000 |
| Net cash provided by financing activities | 46,610,300 | 40,210,600 | 19,211,400 | 6,060,600 |
| Net change in cash, cash equivalents and restricted cash | 49,700,400 | 42,351,700 | 20,312,000 | 8,675,900 |
| Cash and cash equivalents at beginning of period | 101,794,100 | 101,794,100 | 101,794,100 | 93,109,700 |
| Cash and cash equivalents at end of period | 151,494,500 | 144,145,800 | 122,106,100 | 101,785,600 |
CME GROUP INC. (CME)
CME GROUP INC. (CME)